Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2022
Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell LymphomaZijun Y Xu-Monette, Li Wei, Xiaosheng Fang, et al.Oncotarget|November 18, 2015
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphomaQing Ye, Zijun Y Xu-Monette, Alexandar Tzankov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphomaChi Young Ok, Jiayu Chen, Zijun Y Xu-Monette, et al.Aging|December 13, 2016
RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphomaMingzhi Zhang, Zijun Y Xu-Monette, Ling Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2023
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCLZijun Y Xu-Monette, Yong Li, Thomas Snyder, et al.Journal of Hematology & Oncology|November 5, 2020
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53Manman Deng, Mingzhi Zhang, Zijun Y Xu-Monette, et al.Oncoimmunology|August 5, 2021
Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphomaHua You, Zijun Y Xu-Monette, Li Wei, et al.Oncotarget|September 2, 2015
Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphomaLing Li, Zijun Y Xu-Monette, Chi Young Ok, et al.Aging|February 17, 2016
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor functionZijun Y Xu-Monette, Shanxiang Zhang, Xin Li, et al.Oncoimmunology|August 7, 2024
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphomaZijun Y Xu-Monette, Cancan Luo, Li Yu, et al.Pageof 8